167 related articles for article (PubMed ID: 25605015)
1. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.
Hamilton DH; Fernando RI; Schlom J; Palena C
Oncotarget; 2015 Mar; 6(7):4853-62. PubMed ID: 25605015
[TBL] [Abstract][Full Text] [Related]
2. T-box transcription factor brachyury is associated with prostate cancer progression and aggressiveness.
Pinto F; Pértega-Gomes N; Pereira MS; Vizcaíno JR; Monteiro P; Henrique RM; Baltazar F; Andrade RP; Reis RM
Clin Cancer Res; 2014 Sep; 20(18):4949-61. PubMed ID: 25009296
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
[TBL] [Abstract][Full Text] [Related]
5. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.
Palena C; Polev DE; Tsang KY; Fernando RI; Litzinger M; Krukovskaya LL; Baranova AV; Kozlov AP; Schlom J
Clin Cancer Res; 2007 Apr; 13(8):2471-8. PubMed ID: 17438107
[TBL] [Abstract][Full Text] [Related]
6. Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
Hamilton DH; Litzinger MT; Jales A; Huang B; Fernando RI; Hodge JW; Ardiani A; Apelian D; Schlom J; Palena C
Oncotarget; 2013 Oct; 4(10):1777-90. PubMed ID: 24125763
[TBL] [Abstract][Full Text] [Related]
7. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
[TBL] [Abstract][Full Text] [Related]
8. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.
Roselli M; Fernando RI; Guadagni F; Spila A; Alessandroni J; Palmirotta R; Costarelli L; Litzinger M; Hamilton D; Huang B; Tucker J; Tsang KY; Schlom J; Palena C
Clin Cancer Res; 2012 Jul; 18(14):3868-79. PubMed ID: 22611028
[TBL] [Abstract][Full Text] [Related]
9. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.
Hamilton DH; Litzinger MT; Fernando RI; Huang B; Palena C
Semin Oncol; 2012 Jun; 39(3):358-66. PubMed ID: 22595058
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.
Shimamatsu S; Okamoto T; Haro A; Kitahara H; Kohno M; Morodomi Y; Tagawa T; Okano S; Oda Y; Maehara Y
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1012-1020. PubMed ID: 27600618
[TBL] [Abstract][Full Text] [Related]
11. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
[TBL] [Abstract][Full Text] [Related]
12. Chordoma: Immunohistochemical Analysis of Brachury.
Sun HI; Guduk M; Gucyetmez B; Yapicier O; Pamir MN
Turk Neurosurg; 2018; 28(2):174-178. PubMed ID: 28094431
[TBL] [Abstract][Full Text] [Related]
13. Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.
Hamilton DH; David JM; Dominguez C; Palena C
Cells Tissues Organs; 2017; 203(2):128-138. PubMed ID: 28214895
[TBL] [Abstract][Full Text] [Related]
14. Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.
Hamilton DH; Roselli M; Ferroni P; Costarelli L; Cavaliere F; Taffuri M; Palena C; Guadagni F
Endocr Relat Cancer; 2016 Oct; 23(10):783-796. PubMed ID: 27580659
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
Tucker JA; Jochems C; Boyerinas B; Fallon J; Greiner JW; Palena C; Rodell TC; Schlom J; Tsang KY
Cancer Immunol Immunother; 2014 Dec; 63(12):1307-17. PubMed ID: 25186612
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
Du R; Wu S; Lv X; Fang H; Wu S; Kang J
J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
[TBL] [Abstract][Full Text] [Related]
17. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
Song W; Gobe GC
Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
[TBL] [Abstract][Full Text] [Related]
18. Brachyury promotes tamoxifen resistance in breast cancer by targeting SIRT1.
Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
Biomed Pharmacother; 2016 Dec; 84():28-33. PubMed ID: 27621036
[TBL] [Abstract][Full Text] [Related]
19. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
Xu K; Liu B; Liu Y
Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
[TBL] [Abstract][Full Text] [Related]
20. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
